Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $2.00
12% from low
Exchange
OTC Link
ADRC
BIOPHYTIS SA SP/ADR
No one on the platform currently holds BPTSY.
No tracked institution reports a position in BPTSY as of their last filing.
No one on the platform has traded BPTSY yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2M | +30.4% | $-0.81 | $-0.81–$-0.81 | — | 1 |
| 2027 | $0 | -100.0% | $-0.81 | $-0.81–$-0.81 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-04-09 | $-1.22 | $-0.83 | +32.0% |
| 2023-12-30 | $-0.00 | $-2.44 | -79961.3% |
| 2023-07-21 | $-1.83 | $-4.74 | -158.7% |
| 2023-04-18 | $-4.85 | $-11.71 | -141.6% |
| $50009 |
| — |
| PFNDPathfinder Cell Therapy, Inc. | $0.00 | +0.00% | $66716 | — |
| RASPActavia Life Sciences, Inc. | $0.00 | +0.00% | $385906 | — |
Source: Financial Modeling Prep · peers by sector/industry